SCHEMBL4902970

SCHEMBL4902970

CCN(c1ccc(OCc2ccc(C)cc2)cc1)S(=O)(=O)c1ccc(C)c(C(=O)OC)c1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.48
NFE2L2 Q16236 1/20 0.48
KMT2A Q03164 1/20 0.48
CNR1 P21554 1/20 0.46
CNR2 P34972 1/20 0.46
MMP9 P14780 1/20 0.46
MMP13 P45452 1/20 0.46
ADAM17 P78536 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
ALDH1A1 P00352 2/20 0.45
HCRTR2 O43614 2/20 0.45
LMNA P02545 1/20 0.45
MAPT P10636 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
KDM4E B2RXH2 1/20 0.45
GAA P10253 1/20 0.44
PKM P14618 1/20 0.44
TSHR P16473 1/20 0.44
ATM Q13315 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4895775 0.92 ALDH1A1 (0.48) KMT2ACNR1CNR2MMP9MMP13
SCHEMBL4904032 0.92 KEAP1 (0.49) KEAP1NFE2L2KMT2ACNR1CNR2
SCHEMBL4905129 0.92 MMP13 (0.52) KEAP1NFE2L2MMP9MMP13ADAM17
SCHEMBL4904214 0.92 MMP13 (0.46) KMT2AMMP9MMP13ADAM17NPSR1
SCHEMBL4895352 0.90 KMT2A (0.54) KEAP1NFE2L2KMT2ACNR1CNR2
SCHEMBL4899758 0.90 MMP2 (0.49) KEAP1NFE2L2MMP9MMP13NPSR1
SCHEMBL4906453 0.89 LMNA (0.48) KEAP1NFE2L2MMP9MMP13ADAM17
SCHEMBL4906221 0.89 MMP9 (0.47) KEAP1NFE2L2MMP9MMP13ADAM17
SCHEMBL4905482 0.87 NPSR1 (0.51) KEAP1NFE2L2NPSR1ALDH1A1HCRTR2
SCHEMBL4906982 0.85 ALDH1A1 (0.41) KEAP1NFE2L2KMT2AMMP9MMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD KEAP1 714/4885NFE2L2 451/4885KMT2A 3602/4885
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD KEAP1 810/4885NFE2L2 446/4885KMT2A 3530/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD KEAP1 810/4885NFE2L2 446/4885KMT2A 3530/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.